BRD9 and acute myeloid leukemia: We find that BRD9 bromodomain inhibition effectively reduces cell growth in all five AML cell lines, paralleling viability defects observed in BRD9 depletion (4, 66, 107) with much milder effects in HEK293T cells (Fig. 1A).